Family Medicine · Florence, SC
NPI
1437122439
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
800 E Cheves St, Ste 310
Florence, SC, 29506
Phone (843) 679-7272
Groups this clinician bills Medicare through
Medicare paid, 2024
$222K
6,027 services
Medicare patients, 2024
602
Average age 75
Drug cost, 2024
$1.8M
16,645 prescriptions
Company payments, 2025
$2,332
From 30 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Donald A Behling was code J1010 (injection, methylprednisolone acetate, 1 mg), 1,360 times for 16 patients. In total Donald A Behling billed 6,027 services in 71 codes, and Medicare paid $222K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-02-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,360 | 16 | $0.09 | $127 |
| 99214 Office E&M - Established | Office | 892 | 496 | $67.16 | $60K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 715 | 400 | $9.98 | $7,136 |
| 99214 Office E&M - Established | Facility | 656 | 470 | $70.14 | $46K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 464 | 310 | $12.18 | $5,653 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 195 | 195 | $118.54 | $23K |
| 99213 Office E&M - Established | Office | 192 | 154 | $49.92 | $9,584 |
| 99213 Office E&M - Established | Facility | 148 | 128 | $46.84 | $6,933 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 147 | 147 | $112.02 | $16K |
| 96372 Injection Administration | Office | 129 | 44 | $6.71 | $866 |
| 87804 Immunoassay | Office | 128 | 58 | $16.01 | $2,050 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 120 | 12 | $0.05 | $6.47 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 115 | 29 | $0.69 | $79.71 |
| 87811 Immunoassay | Office | 74 | 68 | $40.00 | $2,960 |
| 99211 Office E&M - Established | Office | 44 | 23 | $11.21 | $493 |
By year: 2022 $278K for 4,428 services; 2023 $282K for 4,633 services; 2024 $222K for 6,027 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87804 Immunoassay | 128 | 58 | $16.01 | $2,050 |
| 87811 Immunoassay | 74 | 68 | $40.00 | $2,960 |
| 81003 Clinical Chemistry | 42 | 37 | $2.20 | $92.4 |
| 87880 Immunoassay | 28 | 27 | $16.20 | $454 |
Medicare prescription drug claims, 2024
In 2024, the drug Donald A Behling prescribed most often to Medicare patients was Atorvastatin Calcium, with 932 prescriptions and refills. In total Donald A Behling wrote 16,645 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 932 | 2,395 | 237 | $10K |
| Amlodipine Besylate Generic | 731 | 1,895 | 194 | $4,060 |
| Levothyroxine Sodium Generic | 555 | 1,344 | 125 | $5,878 |
| Metoprolol Succinate Generic | 521 | 1,269 | 130 | $7,719 |
| Rosuvastatin Calcium Generic | 466 | 1,115 | 121 | $7,687 |
| Pantoprazole Sodium Generic | 454 | 1,151 | 132 | $6,831 |
| Omeprazole Generic | 370 | 895 | 94 | $5,240 |
| Gabapentin Generic | 339 | 779 | 105 | $6,674 |
| Hydrochlorothiazide Generic | 249 | 601 | 65 | $740 |
| Metformin Hcl Er Metformin Hcl | 243 | 662 | 72 | $2,194 |
| Tamsulosin Hcl Generic | 242 | 642 | 66 | $4,235 |
| Eliquis Apixaban | 230 | 371 | 52 | $206K |
| Lisinopril Generic | 226 | 592 | 60 | $1,292 |
| Ozempic Semaglutide | 219 | 284 | 35 | $254K |
| Montelukast Sodium Generic | 201 | 487 | 57 | $2,488 |
Brand drugs: 2,310 claims; generic drugs: 14,246 claims; opioid claims: 495.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Donald A Behling $2,332 ($2,332 in general payments such as food, travel and fees) from 30 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $309.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 14 | $309 |
| Novo Nordisk Inc NVO | 13 | $215 |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $210 |
| Abbvie Inc. ABBV | 18 | $173 |
| Pfizer Inc. PFE | 11 | $156 |
| Corcept Therapeutics CORT | 7 | $147 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 6 | $120 |
| GlaxoSmithKline, LLC. GSK | 7 | $117 |
| Esperion Therapeutics, Inc. ESPR | 5 | $95.82 |
| Lilly USA, LLC LLY | 8 | $90.13 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.